Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.215 USD | -3.45% | -0.00% | +113.24% |
Apr. 17 | RBC Raises Price Target on Nuvation Bio to $5 From $4, Keeps Outperform, Speculative Risk | MT |
Apr. 10 | Nuvation Bio Closes Acquisition of AnHeart Therapeutics | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+113.24% | 875M | |
+18.05% | 47.02B | |
+48.77% | 41.86B | |
+0.48% | 41.76B | |
-4.27% | 28.8B | |
+11.81% | 26.05B | |
-22.03% | 19.15B | |
+4.55% | 12.55B | |
+29.31% | 12.34B | |
-3.91% | 11.82B |
- Stock Market
- Equities
- NUVB Stock
- News Nuvation Bio Inc.
- BMO Capital Lowers Nuvation Bio to Market Perform From Outperform, Price Target to $2.50 From $8